Sascha Hinrichsen

ZytoService Deutschland GmbH manufactures and distributes pharmaceutical products. It offers oncological drugs, antibiotics, other parenteral, and pumps. The company was founded by Thomas D. Boner, Enno Scheel, and Thomas Hintz in 2002 and is headquartered in Hamburg, Germany.

alanta health group GmbH operates as a healthcare company. It offers the pharmaceutical manufacturing of patient-specific infusion solutions, the distribution of drugs and medical devices, outpatient and inpatient care, and the conduct of medical studies. The firm specializes in the areas of clinical research, patient care, pharmaceutical trade and healthcare logistics. The company was founded by Enno Scheel and Thomas D. Boner and is headquartered in Hamburg, Germany.

Part of alanta health group GmbH, alanta Investment GmbH provides investment services. The company is based in Hamburg, Germany. The CEOs of the German company are Thomas D. Boner, Enno Scheel, Mirco Schäcke.

Part of alanta health group GmbH, SKH Stadtteilklinik Hamburg GmbH engages in hospital activities. The company is based in Hamburg, Germany. The CEOs of the German company are Bernd Rudloff, Mirco Schäcke, Guido Tuschen.

ZytoService Deutschland GmbH Düsseldorf is a German company that was founded in 2006. Part of GHD GesundHeits GmbH Deutschland, the company is based in Haan, Germany. The CEOs are Axel Dembour and Mirco Schäcke. ZytoService Deutschland GmbH Düsseldorf manufactures oncological pharmaceutical products.

Part of alanta health group GmbH, ZytoService Deutschland GmbH Leipzig is a pharmaceutical company that produces individual parenteral infusion solutions for cancer patients treated in practices and hospitals. ZytoService Deutschland GmbH Leipzig is a leading nationwide production company that produces under the highest standards. The company is based in Leipzig, Germany. The German company focuses on producing oncological therapies tailored to individual requirements of the treating doctors. The CEOs of the company are Mirco Schäcke, Martin Popp.